0001399529-21-000121.txt : 20210617 0001399529-21-000121.hdr.sgml : 20210617 20210617213702 ACCESSION NUMBER: 0001399529-21-000121 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210615 FILED AS OF DATE: 20210617 DATE AS OF CHANGE: 20210617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pagan Douglas W. CENTRAL INDEX KEY: 0001628880 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36281 FILM NUMBER: 211026925 MAIL ADDRESS: STREET 1: 75 KNEELAND STREET CITY: BOSTON STATE: MA ZIP: 02111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc CENTRAL INDEX KEY: 0001399529 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205993609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617 621 8097 MAIL ADDRESS: STREET 1: 75 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 wf-form4_162398020794290.xml FORM 4 X0306 4 2021-06-15 0 0001399529 Dicerna Pharmaceuticals Inc DRNA 0001628880 Pagan Douglas W. C/O DICERNA PHARMACEUTICALS, INC. 75 HAYDEN AVENUE LEXINGTON MA 02421 0 1 0 0 Chief Financial Officer Common Stock 2021-06-15 4 M 0 6825 A 7764 D Common Stock 2021-06-15 4 F 0 2004 35.74 D 5760 D Restricted Stock Units 2021-06-15 4 M 0 6825 0 D Common Stock 6825.0 20475 D Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock. Includes shares acquired under the DRNA 2014 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c). Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Represents RSUs that vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of June 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date. /s/ Douglas Fambrough, attorney-in-fact 2021-06-17